Blog

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributor Brian Orelli analyzes Gilead's (NASDAQ: GILD) earnings report and discusses why the

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributor Brian Orelli discusses the current drug developments of biotech companies and assesses

Novavax (NASDAQ: NVAX) investors faced their fair share of volatility last year with the company's multiple EUA filing delays. In this clip from "The Pharma & Biotech Show" on Motley Fool Live

It's easy to pile on Moderna (NASDAQ: MRNA) these days. The sizzle from earlier in the pandemic has definitely fizzled. Moderna's current downtrend dates back to September 2021. The new year hasn't

Investors should not look for life-changing returns in the stock market to come in a day or a year. Rather, the keys to generating powerful returns are patience and commitment. Patience is needed to

With shares down by more than 45% from the highs, Shopify (NYSE: SHOP) has certainly been an underperformer recently. However, in this Motley Fool Live video clip, recorded on Jan. 27, Fool.com

Since workers at two Starbucks (NASDAQ: SBUX) stores in Buffalo, New York, voted to unionize late last year, the labor movement has taken on growing momentum in the coffee chain, spreading to a

Empire State Realty Trust (NYSE: ESRT) has primarily owned office buildings for much of its history, but recently added New York City apartment buildings to the portfolio. In this Fool Live video

Though we're pretty early on in this year's tax season, some filers might soon start seeing their refunds hit their bank accounts. If you're getting a pile of cash back from the IRS this year, you

PayPal Holdings (NASDAQ: PYPL) got off to a rough start in 2022, as investors continued their transition away from tech stocks and into value-oriented companies in order to combat rising interest

Collaboration software company Atlassian (NASDAQ: TEAM) crushed its latest earnings report in several categories, but one segment's numbers especially stood out. In this episode of "3 Minute Stocks

On Feb. 8 of last year, shares of the coronavirus vaccine developer Novavax (NASDAQ: NVAX) commanded a price near $319, with the market's fervor for its jab feeding more and more into the hype. Of

Knowing when you'll quit the workforce is a crucial part of retirement planning, but few people give as much attention to where they're going to retire. Yet it's worth thinking about if you haven't

Two of investors' all-time favorite cannabis companies released quarterly results last week. Canada-based Aurora Cannabis (NASDAQ: ACB) and Canopy Growth (NASDAQ: CGC) have made investors rich in

So far, 2022 has certainly caused its fair share of heart palpitations as market volatility continues. With the S&P 500 down more than 6% at the time of this writing, it may not seem like a great

Late last month, Japan's Ministry of Health, Labour and Welfare (MHLW) approved Amgen's (NASDAQ: AMGN) Lumakras to treat advanced non-small cell lung cancer (NSCLC) adult patients with the KRAS G12C

In this segment from Backstage Pass, recorded on Feb. 4, Motley Fool contributor Rachel Warren speaks with Tim Schlidt, co-founder and partner at psychedelic investment fund Palo Santo, about his

Pfizer (NYSE: PFE) recently reported billions of dollars in revenue last year thanks to its coronavirus vaccine. And the big pharma company predicts its vaccine and new coronavirus treatment

Don't think the slump for biotech stocks that began last year will go on forever. Of course, not all biotechs experienced the doldrums in the first place. But many of the stocks that did should be

Over the very long-term, the stock market has been a wealth-building machine that's doubled investors' money, on average, about once a decade. But in recent years, cryptocurrencies have run circles

JPMorgan analyst Tien-tsin Huang recently gave Block (NYSE: SQ) an "overweight" rating with a price target of $200. Huang says that Block's acquisition of buy now, pay later fintech Afterpay will

Shares of Affirm Holdings (NASDAQ: AFRM) recently lost over a fifth of their value overnight after delivering mixed results for its fiscal second quarter ended Dec. 31, 2021. The company's latest

Though the stock market can be intimidating at times, it's one of the best ways to generate wealth. In fact, even if you can only afford to invest a little cash each month, it's possible to

Just because a stock's price has dropped doesn't make it a great buy. In this segment of Backstage Pass recorded on Jan. 28, Fool contributors Toby Bordelon, Jason Hall, and Jon Quast discuss the

There's no shortage of sustained double-digit growth opportunities over the next decade. Cybersecurity, cloud computing, and telehealth are all examples of fast-growing trends that investors can't